Fixed-dose combinations (FDCs) have become increasingly prevalent across multiple therapeutic areas, offering the advantage of simplified treatment regimens and improved patient adherence. By combining two or more active agents into a single formulation, FDCs can reduce pill burden, enhance convenience, and, in certain conditions such as hypertension, diabetes, and infectious diseases, provide synergistic therapeutic benefits. These advantages make FDCs particularly valuable in chronic disease management and resource-limited settings.
However, the growing reliance on FDCs also raises important clinical considerations. Not all combinations are rational or evidence-based, and inappropriate FDCs may expose patients to unnecessary medications, increase the risk of adverse effects, or complicate dose titration. In some cases, fixed dosing may not allow flexibility to tailor therapy…